New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 13, 2012
13:59 EDTHLXHelix Energy expects sale to close in 1Q13, to use proceeds to repay debt
The transaction has an effective date of December 1 and is expected to close in 1Q13, customary closing conditions. The divestment of ERT is in line with Helix's strategy of focusing on providing Well Intervention and Robotics services, and Helix intends to use the proceeds from this transaction to repay debt as well as accelerate the company's plans to grow these businesses.
News For HLX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
February 26, 2015
18:02 EDTHLXHelix Energy and BP amend and defer multi-year Q5000 contract
Subscribe for More Information
February 25, 2015
10:17 EDTHLXHelix Energy management to meet with SunTrust
Subscribe for More Information
February 18, 2015
10:05 EDTHLXOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
07:26 EDTHLXHelix Energy downgraded to Market Perform from Outperform at Raymond James
Subscribe for More Information
February 17, 2015
09:20 EDTHLXOn The Fly: Pre-market Movers
UP AFTER EARNINGS: Vipshop Holdings (VIPS), up 10.9%... VASCO Data Security (VDSI), up 7.1%... Waste Management (WM), up 3.7%. ALSO HIGHER: Starwood Hotels (HOT), up 1.9% after appointing Adam Aron as interim CEO... Sarepta Therapeutics (SRPT), up 7.3% after being upgraded at BofA/Merrill... Navidea Biopharmaceuticals (NAVB), up 7.5% after publishing results of phase 3 Lymphoseek trial... Campus Crest (CCG), up 7.7% after announcing that it will explore strategic alternatives as well as Clinton Group and Campus Evolution proxy contest... Cyren (CYRN), up 7.1% following distribution agreement with ALSO Deutschland. DOWN AFTER EARNINGS: Helix Energy (HLX), down 13.3%... Walter Energy (WLT), down 10.1%. ALSO LOWER: Celsus Therapeutics (CLTX), down 82.3% after MRX-6 Cream 2% Phase II trial did not meet primary endpoint... Vascular Biogenics (VBLT), down 53.2% after reporting that VB-201 Phase 2 studies did not meet primary endpoints and removal of FDA partial clinical hold on VB-111... Vanguard Natural Resources (VNR), down 7.1% after reporting preliminary fourth quarter results.
February 16, 2015
18:59 EDTHLXHelix Energy reports Q4 EPS 8c, consensus 24c
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use